Correlation Between Transgene and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Transgene and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transgene and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transgene SA and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Transgene and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transgene with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transgene and Lipella Pharmaceuticals.
Diversification Opportunities for Transgene and Lipella Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Transgene and Lipella is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Transgene SA and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Transgene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transgene SA are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Transgene i.e., Transgene and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Transgene and Lipella Pharmaceuticals
Assuming the 90 days horizon Transgene SA is expected to generate 0.15 times more return on investment than Lipella Pharmaceuticals. However, Transgene SA is 6.58 times less risky than Lipella Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about 0.01 per unit of risk. If you would invest 130.00 in Transgene SA on August 25, 2024 and sell it today you would earn a total of 29.00 from holding Transgene SA or generate 22.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.21% |
| Values | Daily Returns |
Transgene SA vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| Transgene SA |
| Lipella Pharmaceuticals |
Transgene and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Transgene and Lipella Pharmaceuticals
The main advantage of trading using opposite Transgene and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transgene position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| Transgene vs. Akanda Corp | Transgene vs. Cumberland Pharmaceuticals | Transgene vs. Braskem SA Class | Transgene vs. Merit Medical Systems |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |